1-205569086-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181644.5(MFSD4A):c.17G>A(p.Arg6His) variant causes a missense change. The variant allele was found at a frequency of 0.00001 in 1,493,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000045 ( 0 hom. )
Consequence
MFSD4A
NM_181644.5 missense
NM_181644.5 missense
Scores
3
1
14
Clinical Significance
Conservation
PhyloP100: 5.50
Genes affected
MFSD4A (HGNC:25433): (major facilitator superfamily domain containing 4A) Predicted to enable glucose transmembrane transporter activity. Predicted to be involved in glucose transmembrane transport. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10414705).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFSD4A | NM_181644.5 | c.17G>A | p.Arg6His | missense_variant | 1/10 | ENST00000367147.9 | NP_857595.3 | |
MFSD4A-AS1 | NR_027086.2 | n.177+43C>T | intron_variant | |||||
MFSD4A-AS1 | NR_152721.1 | n.177+43C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFSD4A | ENST00000367147.9 | c.17G>A | p.Arg6His | missense_variant | 1/10 | 1 | NM_181644.5 | ENSP00000356115.4 | ||
MFSD4A | ENST00000489709.5 | c.17G>A | p.Arg6His | missense_variant | 1/7 | 5 | ENSP00000478732.1 | |||
MFSD4A | ENST00000475956.5 | n.17G>A | non_coding_transcript_exon_variant | 1/8 | 5 | ENSP00000482239.1 | ||||
MFSD4A | ENST00000539267.5 | n.17G>A | non_coding_transcript_exon_variant | 1/9 | 2 | ENSP00000445329.1 |
Frequencies
GnomAD3 genomes AF: 0.0000529 AC: 8AN: 151348Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
8
AN:
151348
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000363 AC: 4AN: 110074Hom.: 0 AF XY: 0.0000335 AC XY: 2AN XY: 59714
GnomAD3 exomes
AF:
AC:
4
AN:
110074
Hom.:
AF XY:
AC XY:
2
AN XY:
59714
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000447 AC: 6AN: 1342364Hom.: 0 Cov.: 31 AF XY: 0.00000454 AC XY: 3AN XY: 661084
GnomAD4 exome
AF:
AC:
6
AN:
1342364
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
661084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000594 AC: 9AN: 151456Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74004
GnomAD4 genome
AF:
AC:
9
AN:
151456
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
74004
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.17G>A (p.R6H) alteration is located in exon 1 (coding exon 1) of the MFSD4A gene. This alteration results from a G to A substitution at nucleotide position 17, causing the arginine (R) at amino acid position 6 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Loss of methylation at R6 (P = 0.0141);Loss of methylation at R6 (P = 0.0141);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at